Caxton Corp

SEC CIK: 0001388551
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

SABS holding history

SAB Biotherapeutics, Inc. in every 13F filed by Caxton Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SABS overview All 13F holders of SABS Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of SABS by Caxton Corp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−10,527−100.0%	Sold out	Holders
Q4 2025	10,527	$39.4K	0.9%	−408−3.7%	Reduced	Holders
Q3 2025	10,935	$22.0K	0.1%	+10,935	New	Holders